Remove Communication Remove Information Remove Omnicell
article thumbnail

2022 Summer Internships at Omnicell and Advice from Four Former Interns

Omnicell

Morgan Ledford Vice President, Talent Management, Omnicell Omnicell is looking for the best and brightest this summer with internship opportunities across North America. As the Omnicell interns have shown, we care about developing and growing talent. Q: Why should someone consider an internship at Omnicell?

article thumbnail

Simplifying Medication Management Allows Nurses to Focus More on Patient

Omnicell

Len Hom Director, Product Marketing, Point of Care, Omnicell With billions spent on electronic health records (EHR), healthcare providers need other technology to integrate seamlessly with the EHR to create a more cohesive workflow. More than 62 percent of nursing medication transactions are completed remotely through Omnicell's unique mPage.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

At the Precipice of Retail Pharmacy Transformation

Omnicell

They rolled it out very deliberately, allowing pharmacies to get comfortable using the platform and to get patients used to receive refill reminder communications. It also provided valuable information about the patient. Harps decided to move to foundational technology with a medication synchronization platform.

article thumbnail

New National Survey Examines How Retail Pharmacies and Health Plans are Preparing for the COVID-19 Vaccine

Omnicell

69% of pharmacies and 86% of health plans intend to undertake marketing and educational programs to inform their patients/members on the importance of getting the vaccine. 69% of pharmacies and 86% of health plans intend to undertake marketing and educational programs to inform their patients/members on the importance of getting the vaccine.

article thumbnail

Congress Continues to Display Strong Bipartisan Support for the 340B Drug Pricing Program

Omnicell

In response to these actions, various bipartisan groups in Congress have communicated their concerns to the Department of Health and Human Services (HHS) and the Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group representing the pharmaceutical industry in the United States.